Jak2v617f Positive High Risk Polycythemia Vera clinical trials

Explore recruiting jak2v617f positive high risk polycythemia vera clinical trials.

Recruiting jak2v617f positive high risk polycythemia vera studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Jak2v617f Positive High Risk Polycythemia Vera trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL

Hungary, Poland, Italy, Spain, Bulgaria, Croatia +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Jak2v617f Positive High Risk Polycythemia Vera trials by city

Jak2v617f Positive High Risk Polycythemia Vera in Toronto Jak2v617f Positive High Risk Polycythemia Vera in Vancouver Jak2v617f Positive High Risk Polycythemia Vera in Montreal Jak2v617f Positive High Risk Polycythemia Vera in Calgary Jak2v617f Positive High Risk Polycythemia Vera in Edmonton Jak2v617f Positive High Risk Polycythemia Vera in Ottawa Jak2v617f Positive High Risk Polycythemia Vera in Winnipeg Jak2v617f Positive High Risk Polycythemia Vera in Quebec City Jak2v617f Positive High Risk Polycythemia Vera in Hamilton Jak2v617f Positive High Risk Polycythemia Vera in Kitchener Jak2v617f Positive High Risk Polycythemia Vera in London Jak2v617f Positive High Risk Polycythemia Vera in Halifax Jak2v617f Positive High Risk Polycythemia Vera in New York Jak2v617f Positive High Risk Polycythemia Vera in Los Angeles Jak2v617f Positive High Risk Polycythemia Vera in Chicago Jak2v617f Positive High Risk Polycythemia Vera in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease